Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
88 participants
INTERVENTIONAL
2014-12-31
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimal Lidocaine Buffering to Reduce Injection Pain in Local Anesthesia
NCT02647892
Painless Local Anaesthesia With Bicarbonate Admixture
NCT03238625
Clinical Outcomes of Buffered vs. Non-Buffered Lidocaine
NCT02620683
Buffered Lidocaine in the Pediatric Dental Patient
NCT04055116
An Evaluation of the Effectiveness of Local Anesthetics Used During Intravenous Catheter Insertion
NCT02162680
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1% Lidocaine
1% Lidocaine alone.
1% Lidocaine
1% Lidocaine plus sodium bicarbonate
1% Lidocaine plus 8.4% sodium bicarbonate
1% Lidocaine plus sodium bicarbonate
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
1% Lidocaine
1% Lidocaine plus sodium bicarbonate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Any patient scheduled for a breast biopsy at Duke Breast Interventional Imaging
Exclusion Criteria
* Allergic to Lidocaine or Sodium Bicarbonate
* Not mentally capable of consenting
21 Years
89 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jay A Baker, MD
Role: PRINCIPAL_INVESTIGATOR
Duke Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Duke University Medical Center
Durham, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00056728
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.